A new sustained-release microsphere formulation of exenatide, known as DA-3091, has shown promise in managing obesity, diabetes, and nonalcoholic fatty liver disease, offering effective metabolic control with less frequent dosing, potentially improving patient compliance
A good GLP-1 program in Delhi has to account for all of this, not just the prescription itself
Lira Neto JCG, Damasceno MMC, Ciol MA, et al
If nausea is severe, focus on the blander options in this plan (eggs, chicken, yogurt), reduce all portions by 40-50%, eat very slowly, and consider replacing 1-2 solid meals with protein smoothies
Failure to Warn: Eli Lilly had clinical trial data showing risks of severe gastrointestinal issues before Zepbound launched
2024 , hoae017 (2024)